title: Hepatitis C virus in hemodialysis patients.
abstract: Anti-HCV prevalence in 284 hemodialysis patients was assessed using the Abbott HCV-EIA test. Anti-HCV positivity was found in 19.4% of patients, was higher in males than in females and progressively increased with age. A correlation between time of dialysis treatment, transfusions and ALT course was found. These data suggest that HCV infection is a very important risk in dialysis units.
authors.affiliation: Istituto Policattedra Clinica Medica e Malattie Infettive, Università di Bari, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Dentico
authors.forename: A
authors.initials: A
authors.lastname: Volpe
authors.forename: R
authors.initials: R
authors.lastname: Buongiorno
authors.forename: A
authors.initials: A
authors.lastname: Carlone
authors.forename: M
authors.initials: M
authors.lastname: Carbone
authors.forename: M
authors.initials: M
authors.lastname: Manno
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D003428:Cross Infection / Q000201:enzymology / Q000276:immunology / Q000635:transmission; D005260:Female; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000201:enzymology / Q000276:immunology / Q000635:transmission; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors; D065227:Transfusion Reaction
chemical_list: D006508:Hepatitis Antibodies; D000410:Alanine Transaminase